Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$499M |
| 2 |
Synopsys
SNPS
|
+$411M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Netflix
NFLX
|
+$354M |
| 5 |
Cigna
CI
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$546M |
| 2 |
Wells Fargo
WFC
|
+$453M |
| 3 |
PR
Permian Resources
PR
|
+$229M |
| 4 |
Elevance Health
ELV
|
+$195M |
| 5 |
NVIDIA
NVDA
|
+$97.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Healthcare | 23.65% |
| 3 | Communication Services | 11.87% |
| 4 | Financials | 10.29% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Taylor Morrison
TMHC
$6.67B
| – | – |
-3,966
| Closed | -$233K |
|
727
T-Mobile US
TMUS
$183B
| – | – |
-5,199
| Closed | -$1.06M |
|
728
Sixth Street Specialty
TSLX
$1.58B
| – | – |
-67,847
| Closed | -$1.47M |
|
729
TTM Technologies
TTMI
$15B
| – | – |
-6,786
| Closed | -$468K |
|
730
Veeva Systems
VEEV
$29.2B
| – | – |
-5,732
| Closed | -$1.28M |
|
731
VeriSign
VRSN
$23.8B
| – | – |
-5,326
| Closed | -$1.29M |
|
732
Waters Corp
WAT
$37.5B
| – | – |
-4,800
| Closed | -$1.82M |
|
733
Weibo
WB
$1.92B
| – | – |
-637,145
| Closed | -$6.51M |
|
734
Xcel Energy
XEL
$50.4B
| – | – |
-8,385
| Closed | -$619K |
|
|
DAY
735
DELISTED
Dayforce
DAY
| – | – |
-274,848
| Closed | -$19M |
|
|
WRD
736
WeRide Inc
WRD
$1.88B
| – | – |
-12,500
| Closed | -$109K |
|
|
AMTM
737
Amentum Holdings
AMTM
$5.38B
| – | – |
-10,457
| Closed | -$303K |
|
|
IMSR
738
Terrestrial Energy
IMSR
$563M
| – | – |
-11,475
| Closed | -$70.1K |
|
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2026 Portfolio in Review
As of Q1 2026, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $39.1B, down 0.07% from $39.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.59B of net new capital in Q1 2026, opening 84 new positions and adding to 295 existing holdings. Its largest new stake was Synopsys: 910,133 shares worth $361M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Lam Research, an estimated $546M trimmed.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2026 buy was Synopsys: 910,133 shares worth $361M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Mastercard in Q1 2026, an estimated $499M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2026 reduction was Lam Research, cutting an estimated $546M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Comerica in Q1 2026, selling an estimated $36.8M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $39.1B portfolio in Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 0.07% quarter-over-quarter to $39.1B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.